☆ 4.8 Article

CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-& kappa;B/p65 nuclear translocation in pancreatic ductal adenocarcinoma

GUT (2023)

Related references

Note: Only part of the references are listed.

Correction Cell Biology

S100A6 Activates Kupffer Cells via the p-P38 and p-JNK Pathways to Induce Inflammation, Mononuclear/Macrophage Infiltration Sterile Liver Injury in Mice (dec, 10.1007/s10753-022-01750-w, 2022)

He Tong et al.

INFLAMMATION (2023)

Add to Collection

Review Oncology

Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways

Lukas Kraehenbuehl et al.

Summary: The discovery and clinical implementation of immune-checkpoint inhibitors like CTLA4, PD-1, and PD-L1 have significantly improved outcomes for patients with advanced-stage cancers. However, a majority of patients do not respond to these agents, emphasizing the need for further research into alternative immunomodulatory pathways and targeting tumor metabolism to enhance treatment efficacy.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

The foundations of immune checkpoint blockade and the ipilimumab approval decennial

Alan J. Korman et al.

Summary: Cancer immunotherapy has significantly impacted patient survival in multiple high-incidence cancer indications over the past decade, mainly due to the success of immune checkpoint blockade (ICB) drugs. These drugs block specific pathways to attenuate T cell activation, prevent, or reverse, acquired peripheral tolerance, leading to their effectiveness.

NATURE REVIEWS DRUG DISCOVERY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment

Laura D. Wood et al.

Summary: This review discusses the pathogenesis, early detection methods, and treatment considerations of pancreatic ductal adenocarcinoma (PDAC). Recent advances in understanding PDAC have led to significant improvements in detection and treatment, but coordinated efforts are needed to maximize clinical impact for patients and overall survival.

GASTROENTEROLOGY (2022)

Add to Collection

Article Genetics & Heredity

Comprehensive Analysis of CRIP1 Expression in Acute Myeloid Leukemia

Yan Gao et al.

Summary: This study used single-cell RNA sequencing and gene expression data to analyze the expression and role of CRIP1 in AML patients. The results revealed that CRIP1 expression is associated with immune-related pathways and cell infiltration. Methylation data also showed a negative correlation between CRIP1 expression and certain CpG probes. These findings provide insights into the regulation of CRIP1 expression in AML patients and the potential impact on immune heterogeneity.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Immunology

MDSC: Markers, development, states, and unaddressed complexity

Samarth Hegde et al.

Summary: MDSCs are a widely discussed biological entity in immunology, commonly describing cells that arise during chronic inflammation with T cell immunosuppressive functions. Currently lacking clear definitions and a unifying framework across pathologies, we propose a framework based on activation signals to classify MDSCs as discrete cell states. Developing this knowledge of myeloid states across pathological conditions may transform how diseases are grouped and treated.

IMMUNITY (2021)

Add to Collection

Review Immunology

Chemokines and the immune response to cancer

Aleksandra J. Ozga et al.

Summary: Chemokines play a critical role in directing immune cell migration and are involved in shaping the tumor-promoting microenvironment.

IMMUNITY (2021)

Add to Collection

Article Medicine, General & Internal

Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression

Kai Chen et al.

Summary: This study utilized single-cell RNA sequencing to explore the dynamic changes of tumor microenvironment components during PDAC malignant progression, revealing gradual accumulation of immune cells and pancreatic stellate cells. New Treg and exhausted T cell signature genes were identified, and patients with high expression of certain genes had significantly worse prognosis. A new subset of CAFs specific to PDAC, csCAFs, was also discovered.

EBIOMEDICINE (2021)

Add to Collection

Article Oncology

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)

Lori J. Goldstein et al.

Summary: The addition of reparixin to first-line therapy with paclitaxel did not significantly prolong progression-free survival in metastatic triple-negative breast cancer patients.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Add to Collection

Article Biochemistry & Molecular Biology

CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy

Huiying Sun et al.

Summary: The study reveals that CRIP1 downregulation in gastric cancer cells results in HR repair deficiency and increased sensitivity to various chemotherapeutic drugs. CRIP1 promotes HR repair through mechanisms such as stabilizing BRCA2 and promoting nuclear enrichment of RAD51. High CRIP1 expression in patient samples correlates with poor prognosis in response to genotoxic treatments in various solid tumors.

ONCOGENE (2021)

Add to Collection

Correction Genetics & Heredity

Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution (vol 33, pg 568, 2020)

Michelle Chan-Seng-Yue et al.

NATURE GENETICS (2020)

Add to Collection

Review Oncology

The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities

Won Jin Ho et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

TIMER2.0 for analysis of tumor-infiltrating immune cells

Taiwen Li et al.

NUCLEIC ACIDS RESEARCH (2020)

Add to Collection

Article Medicine, General & Internal

Pancreatic cancer

Jonathan D Mizrahi et al.

LANCET (2020)

Add to Collection

Article Oncology

Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation

Lanzhi Zhang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Oncology

Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial

Eileen M. O'Reilly et al.

JAMA ONCOLOGY (2019)

Add to Collection

Article Cell Biology

Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms

Ik Sun Kim et al.

NATURE CELL BIOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities

Vinod P. Balachandran et al.

GASTROENTEROLOGY (2019)

Add to Collection

Review Biochemistry & Molecular Biology

The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications

Xiaomeng Liu et al.

MOLECULAR CANCER (2019)

Add to Collection

Article Hematology

Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair

Cathelijn E. M. Aarts et al.

BLOOD ADVANCES (2019)

Add to Collection

Article Gastroenterology & Hepatology

Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma

Timothy M. Nywening et al.

GUT (2018)

Add to Collection

Article Immunology

Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy

Jinyang Li et al.

IMMUNITY (2018)

Add to Collection

Review Immunology

Myeloid-derived suppressor cells coming of age

Filippo Veglia et al.

NATURE IMMUNOLOGY (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies et al.

NATURE MEDICINE (2018)

Add to Collection

Article Medicine, General & Internal

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

T. Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Review Immunology

NF-κB, inflammation, immunity and cancer: coming of age

Koji Taniguchi et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Add to Collection

Article Biochemical Research Methods

histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data

Denis Schapiro et al.

NATURE METHODS (2017)

Add to Collection

Article Cell Biology

The Impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) on Thyroid Carcinoma

Hong-guang Li et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Add to Collection

Article Oncology

Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer

Anne F. Schott et al.

CLINICAL CANCER RESEARCH (2017)

Add to Collection

Review Immunology

The non-canonical NF-κB pathway in immunity and inflammation

Shao-Cong Sun

NATURE REVIEWS IMMUNOLOGY (2017)

Add to Collection

Review Immunology

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

Nisha Nagarsheth et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Add to Collection

Article Oncology

Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies

Kristin G. Anderson et al.

CANCER CELL (2017)

Add to Collection

Article Medicine, General & Internal

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

A. M. M. Eggermont et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection

Article Medicine, General & Internal

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

Martin Reck et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection

Article Oncology

CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma

Timothy Chao et al.

CANCER IMMUNOLOGY RESEARCH (2016)

Add to Collection

Article Oncology

Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2-Dependent Mechanisms

Yumeng Mao et al.

CANCER RESEARCH (2013)

Add to Collection

Article Biochemistry & Molecular Biology

The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancer

Natalie Ludyga et al.

MOLECULAR CANCER (2013)

Add to Collection

Article Multidisciplinary Sciences

Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer

Christine Feig et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Add to Collection

Article Oncology

Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer

Lauren J. Bayne et al.

CANCER CELL (2012)

Add to Collection

Review Biochemistry & Molecular Biology

The importin β binding domain as a master regulator of nucleocytoplasmic transport

Kaylen Lott et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)

Add to Collection

Article Biochemistry & Molecular Biology

Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer

Q. Wang et al.

ONCOGENE (2007)

Add to Collection

Article Immunology

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma

PC Rodriguez et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.